BlackRock Inc. - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 132 filers reported holding VBI VACCINES INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of VBI VACCINES INC
ValueSharesWeighting
Q1 2023$3,872,670
-25.9%
12,781,090
-4.3%
0.00%
Q4 2022$5,225,008
-45.0%
13,359,775
-0.7%
0.00%
Q3 2022$9,497,000
-14.3%
13,456,431
-1.8%
0.00%
Q2 2022$11,082,000
-49.5%
13,707,702
+3.7%
0.00%
-100.0%
Q1 2022$21,947,000
-29.3%
13,221,108
-0.4%
0.00%0.0%
Q4 2021$31,049,000
-22.0%
13,269,221
+3.6%
0.00%0.0%
Q3 2021$39,827,000
-7.7%
12,806,436
-0.6%
0.00%0.0%
Q2 2021$43,157,000
+0.1%
12,882,677
-7.0%
0.00%0.0%
Q1 2021$43,096,000
+18.9%
13,857,474
+5.2%
0.00%0.0%
Q4 2020$36,234,000
+3.6%
13,175,944
+7.8%
0.00%0.0%
Q3 2020$34,970,000
-13.7%
12,227,084
-6.5%
0.00%
-50.0%
Q2 2020$40,536,000
+265.4%
13,076,588
+12.0%
0.00%
+100.0%
Q1 2020$11,095,000
-22.2%
11,678,848
+13.0%
0.00%0.0%
Q4 2019$14,266,000
+587.8%
10,337,329
+134.8%
0.00%
Q3 2019$2,074,000
-58.0%
4,402,985
+4.2%
0.00%
Q2 2019$4,943,000
+1269.3%
4,224,285
+2089.1%
0.00%
Q1 2019$361,000
-93.2%
192,967
-87.3%
0.00%
Q1 2018$5,306,000
-17.7%
1,515,912
+0.4%
0.00%
Q4 2017$6,445,000
+81.5%
1,509,286
+63.7%
0.00%
Q3 2017$3,550,000
-8.9%
922,250
+2.9%
0.00%
Q2 2017$3,898,000
+1099.4%
896,126
+1413.9%
0.00%
Q1 2017$325,00059,1920.00%
Other shareholders
VBI VACCINES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$171,182,0002.49%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$5,839,0000.50%
HighVista Strategies LLC 41,271$129,0000.08%
ArchPoint Investors 65,000$202,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 136,714$425,0000.06%
FNY Investment Advisers, LLC 24,683$76,0000.04%
GRIMES & COMPANY, INC. 257,960$802,0000.04%
Cambridge Investment Research Advisors, Inc. 2,065,953$6,425,0000.03%
Ergoteles LLC 171,127$532,0000.02%
J.W. COLE ADVISORS, INC. 71,100$221,0000.02%
View complete list of VBI VACCINES INC shareholders